NCT00555048 2017-05-24Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic CancerFred Hutchinson Cancer CenterPhase 1/2 Terminated1 enrolled 5 charts
NCT00089037 2011-07-15Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationFred Hutchinson Cancer CenterPhase 1/2 Completed